Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

372.14 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
The Inventory Shield: US Wholesale Data Signals Stability as Markets Brace for New Trade Realities
The latest data from the U.S. Census Bureau, released in late February 2026, suggests a surprising degree of resilience within the American supply chain. Wholesale inventories for December 2025 rose by... 
Via MarketMinute
Topics Economy Supply Chain World Trade
News headline image
Investment Firm Bets Big on ESAB's Welding and Cutting Technology ↗
ESAB delivers welding, cutting, and digital solutions to industrial clients worldwide, spanning sectors from construction to energy. 
Via The Motley Fool
News headline image
Covetrus and MWI Animal Health to Merge
From Cencora
Via Business Wire
Cencora Inc (NYSE:COR) Q1 2026 Earnings: Revenue Misses, EPS Beats, Shares Fall on Guidance ↗
Via Chartmill
News headline image
Cencora Closes $3.0 Billion Senior Notes Offering
From Cencora
Via Business Wire
News headline image
Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a... 
Via StockStory
Topics Economy
News headline image
1 Momentum Stock with Impressive Fundamentals and 2 We Question
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
5 Revealing Analyst Questions From Cencora’s Q4 Earnings Call
Cencora's fourth quarter was marked by a negative market reaction, as revenue missed Wall Street’s expectations despite year-over-year growth. Management attributed performance to continued growth in... 
Via StockStory
Topics Earnings
News headline image
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056
From Cencora
Via Business Wire
News headline image
McKesson (MCK): A Structural Re-rating Driven by Oncology and GLP-1 Momentum
McKesson Corporation (NYSE: MCK) stands today as the undisputed titan of the U.S. pharmaceutical supply chain. While the company has long been a staple of the Fortune 500, its relevance has surged in... 
Via Finterra
Topics Artificial Intelligence Economy Fraud
News headline image
Cencora (COR) Stock Trades Up, Here Is Why
Shares of healthcare distributor Cencora (NYSE:COR) jumped 7.1% in the afternoon session after the company reported first-quarter results that beat profit expectations and raised its full-year... 
Via StockStory
Topics Artificial Intelligence
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts
Healthcare distributor Cencora (NYSE:COR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1%... 
Via StockStory
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Cencora (COR) Q1 2026 Earnings Call Transcript ↗
Cencora (COR) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates
Healthcare distributor Cencora (NYSE:COR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1% above... 
Via StockStory
News headline image
Cencora Reports Fiscal 2026 First Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora (COR) Reports Earnings Tomorrow: What To Expect
Healthcare distributor Cencora (NYSE:COR) will be reporting results this Wednesday before market open. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
News headline image
Cencora Elects Ellen Cooper to Its Board of Directors
From Cencora
Via Business Wire
News headline image
Healthcare Sector Stages Resilient Rebound as Policy Clarity and GLP-1 Innovations Fuel Investor Optimism
The U.S. healthcare sector has entered 2026 on a remarkably strong footing, staging a decisive rebound after a tumultuous 2025. This resurgence is being driven by a rare alignment of legislative... 
Via MarketMinute
Topics Earnings Economy
News headline image
3 Healthcare Stocks with Exciting Potential
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their... 
Via StockStory
Topics Stocks
News headline image
Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release
From Cencora
Via Business Wire
News headline image
2 Large-Cap Stocks Worth Your Attention and 1 We Question
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
Topics Credit Cards
News headline image
Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at health insurance providers stocks,... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR
CRANFORD, NJ — As the 2025 calendar year draws to a close, Citius Oncology, Inc. (Nasdaq: CTOR) has reached a pivotal juncture in its corporate evolution. Following the release of its SEC 10-K filing... 
Via MarketMinute
Topics Economy Regulatory Compliance
News headline image
2 Large-Cap Stocks Worth Investigating and 1 We Find Risky
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
News headline image
Medline’s Blockbuster IPO Ignites Market Optimism: The Largest Debut Since 2021
In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the... 
Via MarketMinute
Topics Economy Initial Public Offering World Trade
News headline image
Medline Industries (MDLN) Deep-Dive: The $54 Billion Return of a Healthcare Titan
The global healthcare landscape shifted decisively on December 16, 2025, with the public market return of Medline Industries (Nasdaq: MDLN). After four years under the stewardship of a private equity... 
Via PredictStreet
Topics Artificial Intelligence Earnings Economy
News headline image
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
From Cencora
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.